19668581

Source:http://linkedlifedata.com/resource/pubmed/id/19668581

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017601, umls-concept:C0030705, umls-concept:C0033568, umls-concept:C0087111, umls-concept:C0205148, umls-concept:C1280500, umls-concept:C1299003
pubmed:dateCreated	2009-8-11
pubmed:abstractText	To quantify changes in tear break-up time (TBUT), corneal staining and ocular surface disease index (OSDI) in glaucoma patients after switching therapy from latanoprost with 0.02% benzalkonium chloride (BAK) to travoprost with sofZia().
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-10617908, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-10657748, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-10815152, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-11783457, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-1203224, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-1495787, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-15220734, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-17050493, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-17142200, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-17224758, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-18362664, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-1960936, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-3898475, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-65897, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-6998034, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-7358482, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-7493237, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-7742279, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-7959096, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-7980134, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-8034210, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-8795365, http://linkedlifedata.com/resource/pubmed/commentcorrection/19668581-9536878
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101321512
pubmed:status	PubMed-not-MEDLINE
pubmed:issn	1177-5467
pubmed:author	pubmed-author:HorsleyMichael BMB, pubmed-author:KahookMalik YMY
pubmed:issnType	Print
pubmed:volume	3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	291-5
pubmed:year	2009
pubmed:articleTitle	Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients.
pubmed:affiliation	Rocky Mountain Lions Eye Institute, Department of Ophthalmology, University of Colorado Denver, Aurora, CO, USA.
pubmed:publicationType	Journal Article